evolve tirzepatide How the weight loss drug is also helping heart failure patients FDA Grants Tirzepatide a New

Without patent protection, no pharmaceutical company can recoup the $100M+ cost of running the clinical trials required for FDA approval

The most important thing is that you take it every day

The authors conclude: In the STEP TEENS trial, treatment with semaglutide 2.4 mg once weekly for 68 weeks was associated with a significant reduction of levels of the liver enzyme alanine aminotransferase compared with placebo. Dr Weghuber adds: Fatty liver disease is the most frequent liver disease in adolescents with no drug therapy currently available

That's not a failure of the medication that's just biology

Jastreboff, MD, PhD, a physician-scientist and founding director of the Yale Obesity Research Center

Arteaga-Henrquez G, Gisbert L, Ramos-Quiroga JA